Examples of research that would be considered responsive to this announcement are listed below for illustrative purposes and are not exclusive of other appropriate activities.
Select a category below to learn more about topics of interest:
- Completion of studies as required by the FDA for IND or Radioactive Drug Research Committee (RDRC) application
- Assessment of devices with regard to performance standards related to the FDA approval process
- Clinical and toxicology studies in support of an Investigational New Drug Application to the FDA
- Clinical studies in support of Pre-Market Approval for biomarkers/medical devices by the FDA.